Australia News Beep | NewsBeep.com
  • News Beep
  • Australia
  • Headlines
  • Business
  • Entertainment
  • Health
  • Science
  • Sports
  • Technology
Australia News Beep | NewsBeep.com
Australia News Beep | NewsBeep.com
  • News Beep
  • Australia
  • Headlines
  • Business
  • Entertainment
  • Health
  • Science
  • Sports
  • Technology

Browsing Tag

treatment options

5 posts
MMedication
U.S. FDA Accepts Teva’s New Drug Application (NDA) and Grants Priority Review for Ecopipam, a First-in-Class Investigational Therapy for Pediatric Patients with Tourette Syndrome
Read More

U.S. FDA Accepts Teva’s New Drug Application (NDA) and Grants Priority Review for Ecopipam, a First-in-Class Investigational Therapy for Pediatric Patients with Tourette Syndrome

  • August 19, 2026
Teva Pharmaceutical Industries Ltd Ecopipam (EBS-101) is a first-in-class selective D1 (dopamine) receptor antagonist with Orphan Drug designation NDA…
HHealthcare
WHO warns global cancer cases could nearly double by 2050
Read More

WHO warns global cancer cases could nearly double by 2050

  • July 8, 2026
The World Health Organization (WHO) said on Wednesday that the number of new cancer cases diagnosed worldwide each…
HHealthcare
U.S. FDA Approves Pfizer’s HYMPAVZI for the Treatment of Two Additional Hemophilia A or B Patient Populations with Significant Medical Need
Read More

U.S. FDA Approves Pfizer’s HYMPAVZI for the Treatment of Two Additional Hemophilia A or B Patient Populations with Significant Medical Need

  • June 11, 2026
Approval expands HYMPAVZI use to now include people with hemophilia A or B ages 12 years and older…
MMedication
What Consumers Should Know About the Reported $49 Compounded Semaglutide Pill, Novo Nordisk Response, and Telehealth Prescription Access in 2026
Read More

What Consumers Should Know About the Reported $49 Compounded Semaglutide Pill, Novo Nordisk Response, and Telehealth Prescription Access in 2026

  • February 6, 2026
Hims An informational overview of reported February 2026 developments, FDA-approved vs. compounded medication distinctions, Wegovy pill category context,…
MMedication
Geron Corporation Presents New Data at ASH 2025 Highlighting the Relationship Between Treatment-Emergent Cytopenias and Clinical Benefit of RYTELO® (Imetelstat) in Lower-Risk MDS
Read More

Geron Corporation Presents New Data at ASH 2025 Highlighting the Relationship Between Treatment-Emergent Cytopenias and Clinical Benefit of RYTELO® (Imetelstat) in Lower-Risk MDS

  • December 9, 2025
Geron Corporation Oral presentation from pooled analyses of the IMerge population suggests that treatment-emergent cytopenias may reflect on-target…
Australia News Beep | NewsBeep.com
www.newsbeep.com